Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha L Mason

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The American Journal of Psychiatry|January 1, 2025
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of DepressionJohannes G Ramaekers, Johannes T Reckweg, Natasha L Mason
Nature Reviews. Neuroscience|May 28, 2021
The why behind the high: determinants of neurocognition during acute cannabis exposureJohannes G Ramaekers, Natasha L Mason, Lilian Kloft, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 28, 2024
Psilocybin and 2C-B at Encoding Distort Episodic FamiliarityManoj K Doss, Pablo Mallaroni, Natasha L Mason, et al.
Frontiers in Psychiatry|September 27, 2021
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of PsychedelicsCato M H de Vos, Natasha L Mason, Kim P C Kuypers
Frontiers in Psychiatry|May 2, 2022
Cannabis Use and Neuroadaptation: A Call for Δ <i></i> -Tetrahydrocannabinol Challenge StudiesJohannes G Ramaekers, Eef L Theunissen, Peter van Ruitenbeek, et al.
Journal of Psychoactive Drugs|March 26, 2019
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-BeingNatasha L Mason, Elisabeth Mischler, Malin V Uthaug, et al.
Molecular Psychiatry|February 3, 2026
Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinPablo Mallaroni, S Parker Singleton, Natasha L Mason, et al.
Frontiers in Psychiatry|October 2, 2019
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among MicrodosersNadia R P W Hutten, Natasha L Mason, Patrick C Dolder, et al.
The International Journal of Neuropsychopharmacology|June 2, 2019
Motives and Side-Effects of Microdosing With Psychedelics Among UsersNadia R P W Hutten, Natasha L Mason, Patrick C Dolder, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 8, 2024
Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic BoundlessnessSepehr Mortaheb, Larry D Fort, Natasha L Mason, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of Psychiatry|January 1, 2025
Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of DepressionJohannes G Ramaekers, Johannes T Reckweg, Natasha L Mason
Nature Reviews. Neuroscience|May 28, 2021
The why behind the high: determinants of neurocognition during acute cannabis exposureJohannes G Ramaekers, Natasha L Mason, Lilian Kloft, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|June 28, 2024
Psilocybin and 2C-B at Encoding Distort Episodic FamiliarityManoj K Doss, Pablo Mallaroni, Natasha L Mason, et al.
Frontiers in Psychiatry|September 27, 2021
Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of PsychedelicsCato M H de Vos, Natasha L Mason, Kim P C Kuypers
Frontiers in Psychiatry|May 2, 2022
Cannabis Use and Neuroadaptation: A Call for Δ <i></i> -Tetrahydrocannabinol Challenge StudiesJohannes G Ramaekers, Eef L Theunissen, Peter van Ruitenbeek, et al.
Journal of Psychoactive Drugs|March 26, 2019
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-BeingNatasha L Mason, Elisabeth Mischler, Malin V Uthaug, et al.
Molecular Psychiatry|February 3, 2026
Spatiotemporal mapping of brain organisation following the administration of 2C-B and psilocybinPablo Mallaroni, S Parker Singleton, Natasha L Mason, et al.
Frontiers in Psychiatry|October 2, 2019
Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among MicrodosersNadia R P W Hutten, Natasha L Mason, Patrick C Dolder, et al.
The International Journal of Neuropsychopharmacology|June 2, 2019
Motives and Side-Effects of Microdosing With Psychedelics Among UsersNadia R P W Hutten, Natasha L Mason, Patrick C Dolder, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|April 8, 2024
Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic BoundlessnessSepehr Mortaheb, Larry D Fort, Natasha L Mason, et al.
Pageof 5